9 years ago
Break Up the Insulin Racket
The World Health Organization considers it an essential medicine, which means it should be available “at a price the individual and the community can afford.” So why is this product increasingly too expensive for many Americans? In the United States, just three pharmaceutical giants hold patents that allow them to manufacture insulin: Eli Lilly, Sanofi and Novo Nordisk. By Kasia Lipska. (Feb. 20)
Continue Reading
http://www.nytimes.com
-
Insulin shortage could affect 50,000 people with diabetes in the UK
As many as 50,000 people with diabetes may need to be switched to alternative insulin injections, with certain insulin products expected to be in short supply. By Kurt Wood. (Dec. 23) -
Parents turn into med-tech hackers to help their kids with diabetes
Parents eager to tailor off-the-shelf devices into homemade solutions have set in motion a remarkable, egalitarian push for improved technology to manage diabetes care. By Peter Andrey Smith.
Join the Discussion